Good candidates for bariatric surgery are those with a body mass index (BMI) over 40, or between 35 and 40 with additional weight-related health issues like type 2 diabetes
Clinical Efficacy, Individual Response, and Biomarker Context Both Ozempic and compounded semaglutide work through the same mechanismGLP-1 receptor agonismso clinical efficacy is primarily determined by dose consistency, patient adherence, and individual genetic and metabolic factors rather than brand
Improved metabolic flexibility Obesity and type 2 diabetes are commonly associated with impaired metabolic flexibility, meaning the body has difficulty switching efficiently between glucose and fat oxidation
The study highlights the potential benefits of semaglutide in long-term diabetes management, emphasizing the importance of a holistic approach that combines medication with lifestyle changes
Rationale for the Recommendation Semaglutide (Wegovy) was reviewed by CDEC in October 2022 for the indication as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index of 30 kg/m 2 or greater (obesity), or 27 kg/m 2 or greater (overweight) in the presence of at least 1 weight-related comorbidity such as hypertension, type 2 diabetes mellitus (T2DM), dyslipidemia, or obstructive sleep apnea and was not recommended for reimbursement
Which Works Better for a Natural Glow